test 8 history of bridge to transport Flashcards
History - VAD as A BTT
Transplantation provided a stimulus for the development of VADs for support until transplant.
Early 1980s – Transplantation became a widely applied therapy.
30% of patients died on the list
Became an incentive to develop devices that could be used for patients with acute cardiac decompensation while awaiting transplantation.
1980
– NIH sent out request for proposals
To develop an “implantable, integrated, electrically powered left heart assist system” that could be used on a long term basis and allow extensive patient mobility.
9/1984 – Stanford University
Oyer and Colleagues – Implanted the Novacor LVAD
1st successful transplant s/p BTT with LVAD
Followed by Hill and colleagues who implanted a Pearce-Donachey pneumatic LVAD.
1992
– Frazier and colleagues
1st to report successful BTT with Thoratec Heartmate IP VAD
Implantable Pneumatic
Restored near normal hemodynamics.
Limitations –
Devices dependent on large consoles for power and controller function
Patients confined to hospital until transplantation despite being fully ambulatory.
1990
– Kormos at University of Pittsburg
Developed a program to transfer VAD patients to a monitored outpatient setting until transplantation.
1991
– Frazier at Texas Heart Institute
First to use an untethered Vented Electric LVAD for long term support
33 y/o patient
Battery operated Heartmate VE
500 days of support
Patient died of embolic cerebral vascular accident.
1990s
– FDA sponsored several multi-institution trials of assist devices as bridge to transplant and bridge to recovery.
1994
– Heartmate LVAD was the first FDA approved implantable device for bridge to transplant.